APA (7th ed.) Citation

K, S., K, L., A, J., M, S., S, I., MJ, D., . . . K, P. (2026). Sigma-1-targeting multimodal compound HBK-15 reverses memory deficits and restores hippocampal plasticity under NMDA hypofunction. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 23(1), e00774. https://doi.org/10.1016/j.neurot.2025.e00774

Chicago Style (17th ed.) Citation

K, Sałaciak, et al. "Sigma-1-targeting Multimodal Compound HBK-15 Reverses Memory Deficits and Restores Hippocampal Plasticity Under NMDA Hypofunction." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 23, no. 1 (2026): e00774. https://doi.org/10.1016/j.neurot.2025.e00774.

MLA (9th ed.) Citation

K, Sałaciak, et al. "Sigma-1-targeting Multimodal Compound HBK-15 Reverses Memory Deficits and Restores Hippocampal Plasticity Under NMDA Hypofunction." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, vol. 23, no. 1, 2026, p. e00774, https://doi.org/10.1016/j.neurot.2025.e00774.